Motive Expands AI Platform to Automate Driver Qualification, Compliance and Workforce Records Management, Saving Teams from Time-Consuming Administrative Work February 23, 2026 New AI-powered Workforce Management capabilities eliminate manual document tracking, reduce compliance risk and help prevent costly downtime
Lady Mayor: London must deepen ties with America’s emerging powerhouses February 23, 2026 The US is more than just two coasts. Miami, Dallas and Texas are booking and London is perfectly placed to feel the benefits, says Susan Langley A huge part of the impact of the mayoralty is the 100 days spent overseas, championing the sector and deepening relationships in key markets. When people talk about UK-US [...]
Toshiba Showcases End-to-End Innovations Shaping What’s Next in Retail at EuroShop 2026 February 23, 2026 At EuroShop, Toshiba showcases intelligent, scalable solutions that combine AI, computer vision, and energy-efficient design to transform the future of retail.
Almirall’s 2025 Results February 23, 2026 Almirall meets guidance for 2025, delivering 12.4% net sales growth and further pipeline progress, continuing its sustained growth trajectory with strong dermatology performance and commercial execution in Europe Almirall delivered net sales growth in 2025 of 12.4% exceeding €1bn (total of €1,108.1MM), revenue increase of 12.5% (total of €1,114.5 MM), and EBITDA growth of 20.9% (total of €232.9 MM) – in line with its guidance and its sustained growth trajectory. This revenue growth further advances Almirall’s leadership in medical dermatology driven by the strong performance of its European dermatology business (+25.6% YoY increase to a total of €608 MM). The continued strong performance of the biologics portfolio is the backbone of Almirall’s growth, with Ilumetri® net sales increasing 12.3% YoY (total of €234.4 MM), and Ebglyss® net sales increasing more than 3x YoY to a total of €110.8 MM – reflecting its strong position and growth trajectory across Europe in the second year after launch. Continued solid performance of the broad dermatology product portfolio with Wynzora® growing 30.5% YoY to a total of €33.8 MM, and Klisyri® growing 33.9% YoY to a total of €32.8 MM, further enhances Almirall’s position as trusted partner for patients and dermatologists. Almirall’s business performance fuels the advancement of a diversified and innovative R&D pipeline addressing skin diseases with high unmet need. Pipeline progress in 2025 included the start of the phase II study of the anti-IL-1RAP mAb in Hidradenitis suppurativa, the start of the phase II study of the IL-2muFc in Alopecia areata, and the approval of Jublia® in Germany and Seysara® in China. Guidance for 2026: net sales growth of 9%-12% and total EBITDA between €270 MM and €290 MM.
How to solve the energy crisis? Give power back to the markets February 23, 2026 Solving the energy crisis needs the dynamism of the private sector, not more government subsidies and central planning, writes Emma Revell.
Hunslet RLFC’s lesson for rugby league profitability? Pay HMRC February 20, 2026 Something incredible happened in the world of English rugby league this week. No, not the World Club Challenge victory for Hull KR over Brisbane Broncos, but a club in Hunslet RLFC turning a profit. Various reports state that, across the latest possible Companies House records, only Leigh Leopards turned a profit, over £500,000 better off [...]
Capitolis to Acquire 20 Gates Management’s U.S. Secured Financing Platform to Expand its Capital Marketplace February 20, 2026 Strategic acquisition enables Capitolis to deliver U.S. secured financing through its Capital Marketplace, broadens client base, and adds veteran industry talent
Premier League Predictions: Chelsea, Liverpool and Manchester United to march on while jittery Arsenal clinch victory in the North London Derby February 20, 2026 Arsenal squandered the chance to move seven points clear at the top of the Premier League last night, and the battle between the Gunners and Manchester City is heating up. Both face big games this weekend, as do members of the chasing pack. At the other end, West Ham could move out of the bottom [...]
Tech CEO Daniel Callaghan: My first job was in a sports shop with Rachel Reeves February 19, 2026 We dig into the memory bank of the City’s great and good. Today, the CEO of one of the UK’s fastest-growing tech firms, Daniel Callaghan.
FTSE 100 Live: Centrica profit falls; Stocks dip after record rally February 19, 2026 Good morning and welcome back to the City AM liveblog. It’s been quite the week for the “old and unexciting” FTSE 100. The blue-chip index closed 1.2 per cent higher on Tuesday led by a rally in the mining sector. Antofagasta led the pack up over 10 per cent, which came a day after its [...]